{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:08:10Z","timestamp":1790744890018,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["400640_160374"],"award-info":[{"award-number":["400640_160374"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009131","name":"Swiss Agency for Development and Cooperation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jval.2025.09.3062","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:55:21Z","timestamp":1760536521000},"page":"1012-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dominance-Based Distributional Cost-Effectiveness Analysis of Cardiovascular Disease Risk Screening in Sri Lanka"],"prefix":"10.1016","volume":"29","author":[{"given":"Nilmini","family":"Wijemunige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"van Baal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra P.","family":"Rannan-Eliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2025.09.3062_bib1","series-title":"WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care","year":"2020"},{"key":"10.1016\/j.jval.2025.09.3062_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.820750","article-title":"Cost-effectiveness of population screening programs for cardiovascular diseases and diabetes in low- and middle-income countries: A systematic review","volume":"10","author":"Sharma","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.jval.2025.09.3062_bib3","series-title":"Resolution adopted by the General Assembly on 25 September 2015. 70\/1. Transforming Our World: the 2030 Agenda for Sustainable Development","year":"2015"},{"key":"10.1016\/j.jval.2025.09.3062_bib4","series-title":"Annual Performance Report; 2022","year":"2022"},{"issue":"2","key":"10.1016\/j.jval.2025.09.3062_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/2224-3151.206258","article-title":"Healthy Lifestyle Centres: a service for screening noncommunicable diseases through primary health-care institutions in Sri Lanka","volume":"5","author":"Mallawaarachchi","year":"2016","journal-title":"WHO S East Asia J Public Health"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib6","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1186\/s12889-023-16640-5","article-title":"Optimizing cardiovascular disease risk screening in a low-resource setting: cost-effectiveness of program modifications in Sri Lanka modelled with nationally representative survey data","volume":"23","author":"Wijemunige","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jval.2025.09.3062_bib7","series-title":"Expanding Health Care Coverage. Research Studies Series. Number 3.","article-title":"Sri Lanka: \u201cgood practice\u201d","author":"Rannan-Eliya","year":"2009"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5334\/gh.1174","article-title":"Cost-effectiveness and distributional impact of opportunistic screening for people at high-risk of cardiovascular disease in Sri Lanka: a modelling study","volume":"17","author":"Wijemunige","year":"2022","journal-title":"Glob Heart"},{"issue":"2","key":"10.1016\/j.jval.2025.09.3062_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jval.2016.11.027","article-title":"Using cost-effectiveness analysis to address health equity concerns","volume":"20","author":"Cookson","year":"2017","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jval.2020.10.001","article-title":"Distributional cost-effectiveness analysis Comes of Age","volume":"24","author":"Cookson","year":"2021","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2025.09.3062_bib12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hec.3058","article-title":"Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme","volume":"24","author":"Asaria","year":"2014","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40273-021-01094-7","article-title":"Incorporating equity concerns in cost-effectiveness analyses: A systematic literature review","volume":"40","author":"Ward","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14737167.2021.1954505","article-title":"Incorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review","volume":"22","author":"Yang","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.jval.2025.09.3062_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/heapol\/czx175","article-title":"Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia","volume":"33","author":"Dawkins","year":"2018","journal-title":"Health Policy Plan"},{"issue":"6","key":"10.1016\/j.jval.2025.09.3062_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/heapol\/czaa015","article-title":"Distributional impact of the Malawian Essential Health Package","volume":"35","author":"Arnold","year":"2020","journal-title":"Health Policy Plan"},{"issue":"3","key":"10.1016\/j.jval.2025.09.3062_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/heapol\/czaa181","article-title":"Equity and economic evaluation of system-level health interventions: A case study of Brazil\u2019s Family Health Program","volume":"36","author":"Love-Koh","year":"2021","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.jval.2025.09.3062_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105879","article-title":"Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis","volume":"130","author":"Collins","year":"2020","journal-title":"Prev Med"},{"key":"10.1016\/j.jval.2025.09.3062_bib19","series-title":"Distributional Cost-Effectiveness Analysis: Quantifying Health Equity Impacts and Trade-Offs","year":"2020"},{"issue":"5","key":"10.1016\/j.jval.2025.09.3062_bib20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jval.2019.03.006","article-title":"Aggregate distributional cost-effectiveness analysis of health technologies","volume":"22","author":"Love-Koh","year":"2019","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2025.09.3062_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0272989X19829726","article-title":"Evaluation of intervention impact on health inequality for resource allocation","volume":"39","author":"Griffin","year":"2019","journal-title":"Med Decis Making"},{"issue":"10","key":"10.1016\/j.jval.2025.09.3062_bib22","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/hec.3430","article-title":"Eliciting the level of health inequality aversion in England","volume":"26","author":"Robson","year":"2017","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2025.09.3062_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2024.102856","article-title":"Aversion to health inequality - Pure, income-related and income-caused","volume":"94","author":"Robson","year":"2024","journal-title":"J Health Econ"},{"key":"10.1016\/j.jval.2025.09.3062_bib24","series-title":"Distributional Cost-Effectiveness Analysis: Quantifying Health Equity Impacts and Trade-Offs","article-title":"Dominance analysis","author":"O\u2019Donnell","year":"2020"},{"issue":"4","key":"10.1016\/j.jval.2025.09.3062_bib25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1215\/00703370-11460856","article-title":"Ranking age-at-death distributions using dominance: robust evaluation of United States mortality trends, 2006-2021","volume":"61","author":"Issa","year":"2024","journal-title":"Demography"},{"issue":"10","key":"10.1016\/j.jval.2025.09.3062_bib26","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1016\/S2214-109X(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jval.2025.09.3062_bib27","series-title":"Ministry of Health","year":"2023"},{"issue":"2","key":"10.1016\/j.jval.2025.09.3062_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyae044","article-title":"Cohort profile: the Sri Lanka Health and Ageing Study (SLHAS)","volume":"53","author":"Rannan-Eliya","year":"2024","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.jval.2025.09.3062_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2125.1999.00092.x","article-title":"The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes","volume":"48","author":"King","year":"1999","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jval.2025.09.3062_bib35","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2214-109X(18)30450-9","article-title":"Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis","volume":"7","author":"Basu","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamainternmed.2017.6015","article-title":"Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis","volume":"178","author":"Brunstrom","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.jval.2025.09.3062_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/qjmed\/hcq165","article-title":"Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials","volume":"104","author":"Mills","year":"2011","journal-title":"QJM"},{"key":"10.1016\/j.jval.2025.09.3062_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vhri.2017.01.001","article-title":"Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L value sets","volume":"12","author":"Kularatna","year":"2017","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.jval.2025.09.3062_bib39","article-title":"Population norms and disutility catalog for chronic conditions in Sri Lanka","volume":"45","author":"Wijemunige","year":"2025","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12962-021-00260-0","article-title":"Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds","volume":"19","author":"Daroudi","year":"2021","journal-title":"Cost Eff Resour Alloc"},{"issue":"8","key":"10.1016\/j.jval.2025.09.3062_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-level cost-effectiveness thresholds: initial estimates and the need for further research","volume":"19","author":"Woods","year":"2016","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2025.09.3062_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib43","first-page":"115","article-title":"Estimating wealth effects without expenditure data--or tears: an application to educational enrollments in states of India","volume":"38","author":"Filmer","year":"2001","journal-title":"Demography"},{"key":"10.1016\/j.jval.2025.09.3062_bib44","series-title":"Methods for the estimation of the NICE cost effectiveness threshold","author":"Claxton","year":"2013"},{"issue":"12","key":"10.1016\/j.jval.2025.09.3062_bib45","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.jval.2025.09.3062_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jacc.2022.04.047","article-title":"Secular trends in risk profiles among adults with cardiovascular disease in the United States","volume":"80","author":"Gao","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jval.2025.09.3062_bib47","series-title":"Distributional Cost-Effectiveness Analysis: Quantifying Health Equity Impacts and Trade-Offs","article-title":"Rank-dependent equity weights","author":"O\u2019Donnell","year":"2020"},{"issue":"4","key":"10.1016\/j.jval.2025.09.3062_bib48","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0167-6296(02)00006-1","article-title":"Inequality aversion, health inequalities and health achievement","volume":"21","author":"Wagstaff","year":"2002","journal-title":"J Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jhealeco.2011.10.009","article-title":"\u201cMirror, mirror, on the wall, who in this land is fairest of all?\u201d--Distributional sensitivity in the measurement of socioeconomic inequality of health","volume":"31","author":"Erreygers","year":"2012","journal-title":"J Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2025.09.3062_bib50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.jval.2025.09.3062_bib51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0022-0531(76)90037-5","article-title":"Unequal inequalities. I","volume":"12","author":"Kolm","year":"1976","journal-title":"J Econ Theor"},{"issue":"3","key":"10.1016\/j.jval.2025.09.3062_bib52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0022-0531(70)90039-6","article-title":"On the measurement of inequality","volume":"2","author":"Atkinson","year":"1970","journal-title":"J Econ Theor"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3062_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR Cheers II good practices task force","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2025.09.3062_bib54","series-title":"Stata Statistical Software","year":"2021"},{"key":"10.1016\/j.jval.2025.09.3062_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.dialog.2023.100137","article-title":"The impact of the Sri Lankan economic crisis on medication adherence: an online cross-sectional survey","volume":"2","author":"Jayawardena","year":"2023","journal-title":"Dialogues Health"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525056190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525056190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:31:14Z","timestamp":1782513074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525056190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1098301525056190"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.09.3062","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dominance-Based Distributional Cost-Effectiveness Analysis of Cardiovascular Disease Risk Screening in Sri Lanka","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.09.3062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}